Metabolic pathways are series of chemical reactions in the human body that convert food into energy and essential molecules. These pathways include processes like glycolysis, the Krebs cycle, and fatty acid metabolism. Disorders occur when these processes malfunction due to genetic mutations, enzyme deficiencies, or other factors, leading to conditions such as diabetes, phenylketonuria, or mitochondrial diseases. Understanding these pathways is crucial for diagnosing, managing, and treating metabolic disorders effectively.
Metabolic pathways are series of chemical reactions in the human body that convert food into energy and essential molecules. These pathways include processes like glycolysis, the Krebs cycle, and fatty acid metabolism. Disorders occur when these processes malfunction due to genetic mutations, enzyme deficiencies, or other factors, leading to conditions such as diabetes, phenylketonuria, or mitochondrial diseases. Understanding these pathways is crucial for diagnosing, managing, and treating metabolic disorders effectively.
What is a metabolic pathway?
A series of enzyme-catalyzed reactions that converts an initial molecule into one or more products through multiple steps, with regulation at key steps to meet the cell’s needs.
Which major pathways generate cellular energy and how do they work together?
Glycolysis breaks glucose into pyruvate in the cytosol, yielding a small amount of ATP and NADH. Pyruvate then enters the mitochondria for the TCA cycle, which produces more NADH and FADH2. The electron transport chain uses those carriers to generate most of the cell’s ATP via oxidative phosphorylation.
What causes metabolic disorders related to enzyme deficiencies?
Inborn errors of metabolism occur when a specific enzyme is missing or not functioning properly, leading to accumulation of substrates or a shortage of products. These conditions are often inherited and can affect organs like the brain, liver, or muscles.
Why are newborn screening tests important for metabolic disorders?
They test newborns for certain metabolic markers soon after birth so affected infants can start treatment early, reducing the risk of serious health problems.